References
- FireAXuSMontgomeryMKKostasSADriverSEMelloCCPotent and specific genetic interference by doublestranded RNA in Caenorhabditis elegansNature199839166698068119486653
- TurchinovichAZoidlGDermietzelRNon-viral siRNA delivery into the mouse retina in vivoBMC Ophthalmology2010102514711475
- LeungRKWhittakerPARNA interference: from gene silencing to gene-specific therapeuticsPharmacol Ther2005107222223915908010
- ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature2001411683649449811373684
- BumcrotDManoharanMKotelianskyVSahDWRNAi therapeutics: a potential new class of pharmaceutical drugsNat Chem Biol200621271171917108989
- ZamorePDTuschlTSharpPABartelDPRNAi: doublestranded RNA directs the ATP-dependent cleavage of mRNA at 21–23 nucleotide intervalsCell20001011253310778853
- ParrishSFleenorJXuSMelloCFireAFunctional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interferenceMol Cell2000651077108711106747
- GuoBZhangYLuoGLiLZhangJLentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinomaAnat Rec (Hoboken)20095292563363919382240
- ChenCSunJLiuGChenJEffect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic micePathol Oncol Res200915110911418509748
- GaoYSMeiJTongTLHuMXueHMCaiXSInhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude miceCancer Biother Radiopharm200924224324719409047
- HöbelSKoburgerIJohnMPolyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with BevacizumabJ Gene Med201012328730020052738
- ZuhornISEngbertsJBHoekstraDGene delivery by cationic lipid vectors: overcoming cellular barriersEur Biophys J20073634936217019592
- PirolloKFChangEHTargeted delivery of small interfering RNA: approaching effective cancer therapiesCancer Res2008681247125018316585
- WangYLiZHanYLiangLHJiANanoparticle-based delivery system for application of siRNA in vivoCurr Drug Metab201011218219620359287
- ChoungSKimYJKimSParkHOChoiYCChemical modification of siRNAs to improve serum stability without loss of efficacyBiochem Biophys Res Commun2006342391992716598842
- MookORBaasFde WisselMBFluiterKEvaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivoMol Cancer Ther20076383384317363479
- Ui-TeiKNaitoYZennoSFunctional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effectNucleic Acids Res20083672136215118267968
- BramsenJBLaursenMBNielsenAFA large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicityNucleic Acids Res20093792867288119282453
- ChiuYLRanaTMsiRNA function in RNAi: a chemical modification analysisRNA2003991034104812923253
- PiekenWAOlsenDBBenselerFAurupHEcksteinFKinetic characterization of ribonucleaseresistant 2′-modified hammerhead ribozymesScience19912533143171857967
- LayzerJMMcCaffreyAPTannerAKHuangZKayMASullengerBAIn vivo activity of nuclease-resistant siRNAsRNA20041076677115100431
- JacksonALBurchardJLeakeDPosition-specific chemical modification of siRNAs reduces “off-target” transcript silencingRNA2006121197120516682562
- GaglioneMMessereARecent progress in chemically modified siRNAsMini Rev Med Chem20101057859520500149
- OverhoffMSczakielGPhosphorothioate-stimulated uptake of short interfering RNA by human cellsEMBO Rep20056121176118116170302
- HallAHWanJShaughnessyEERamsay ShawBAlexanderKARNA interference using boranophosphate siRNAs: structure-activity relationshipsNucleic Acids Res200432205991600015545637
- BehlkeMAChemical modification of siRNAs for in vivo useOligonucleotides200818430531919025401
- TerrazasMKoolETRNA major groove modifications improve siRNA stability and biological activityNucleic Acids Res200937234635319042976
- ChiuYLAliAChuCYCaoHRanaTMVisualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cellsChem Biol20041181165117515324818
- LorenzCHadwigerPJohnMVornlocherHPUnverzagtCSteroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cellsBioorg Med Chem Lett2004144975497715341962
- SoutschekJAkincABramlageBTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature200443217317815538359
- BehlkeMAChemical modification of siRNAs for in vivo useOligonucleotides200818430531919025401
- WattsJKDeleaveyGFDamhaMJChemically modified siRNA: tools and applicationsDrug Discov Today20081384285618614389
- SorianoPDijkstraJLegrandATargeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I geneProc Natl Acad Sci U S A19838023712871316580630
- De FougerollesAVornlocherHPMaraganoreJLiebermanJInterfering with disease: a progress report on siRNA-based therapeuticsNat Rev Drug Discov20076644345317541417
- LiJChenYCTsengYCMozumdarSHuangLBiodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA deliveryJ Control Release2010142341642119919845
- BarichelloJMIshidaTKiwadaHComplexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparationMethods Mol Biol201060546147220072901
- SpagnouSMillerADKellerMLipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNABiochemistry20044342133481335615491141
- PeerDParkEJMorishitaYCarmanCVShimaokaMSystemic leukocyte-directed siRNA delivery revealing cyclin D1 as an antiinflammatory targetScience2008319586362763018239128
- HalderJKamatAALandenCNJrFocal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapyClin Cancer Res200612164916492416914580
- FelgnerPLRingoldGMCationic liposome-mediated transfectionNature198933762053873882463491
- ZhangCTangNLiuXLiangWXuWTorchilinVPsiRNA-containing liposomes modified with polyarginine effectively silence the targeted geneJ Control Release200611222923916545478
- LealCBouxseinNFEwertKKSafinyaCRHighly efficient gene silencing activity of siRNA embedded in a nanostructured gyroid cubic lipid matrixJ Am Chem Soc201013247168411684721028803
- KimWJKimSWEfficient siRNA delivery with non-viral polymeric vehiclesPharm Res200926365766619015957
- HuangAJSuppression of keratoepithelin and myocilin by small interfering RNA (an American Ophthalmological Society thesis)Trans Am Ophthalmol Soc200710536537818427622
- KimWJChangCWLeeMKimSWEfficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapyJ Control Release2007118335736317313987
- PirolloKFRaitAZhouQMaterializing the potential of small interfering RNA via a tumor-targeting nanodelivery systemCancer Res20076772938294317409398
- GuoPCobanOSneadNMEngineering RNA for targeted siRNA delivery and medical applicationAdv Drug Deliv Rev201062665066620230868
- KimDHKangJWKimTRKimEJImJSKimJA polyol-mediated synthesis of titania-based nanoparticles and their electrochemical propertiesJ Nanosci Nanotechnol20077113954395818047095
- KimBHChoMSKimSYDry sol-gel polycondensation of hydrosilanes to organosilicas catalyzed by colloidal nickel nanoparticlesJ Nanosci Nanotechnol20077113964396818047097
- HowardKARahbekULLiuXRNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle systemMol Ther200614447648416829204
- GhosnBSinghALiMEfficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNAOligonucleotides201020316317220565242
- ZintchenkoAPhilippADehshahriAWagnerESimple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicityBioconjug Chem20081971448145518553894
- WangHJZhangSGLiaoZYPEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrierBiomaterials201031256589659620553983
- LuoGJinCLongJRNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticlesCancer Biol Ther20098759459819276660
- KatasHCevherEAlparHOPreparation of polyethyleneimine incorporated poly (D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA deliveryInt J Pharm20093691–214415419010405
- LadeiraMSAndradeVAGomesERHighly efficient siRNA delivery system into human and murine cells using single-wall carbon nanotubesNanotechnology2010213838510120798464
- BonoiuACMahajanSDDingHNanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neuronsProc Natl Acad Sci U S A2009106145546555019307583
- GuoSTschammerNMohammedSGuoPSpecific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNAHum Gene Ther20051691097110916149908
- ShuDMollWDDengZMaoCGuoPBottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnologyNano Lett2004491717172321171616
- TaraporePShuYGuoPHoSMApplication of Phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancersMol Ther201119238639421063391
- DickersonEBBlackburnWHSmithMHKapaLBLyonLAMcDonaldJFChemosensitization of cancer cells by siRNA using targeted nanogel deliveryBMC Cancer20101011120047689
- AgrawalAMinDHSinghNFunctional delivery of siRNA in mice using dendriwormsACS Nano2009932495250419673534
- YoshizawaTHattoriYHakoshimaMKogaKMaitaniYFolate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenograftsEur J Pharm Biopharm200870371872518647651
- DassieJPLiuXYThomasGSSystemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNat Biotechnol200927983984919701187
- LeeKBaeKHLeeYLeeSHAhnCHParkTGPluronic/polyethylenimine shell crosslinked nanocapsules with embedded magnetite nanocrystals for magnetically triggered delivery of siRNAMacromol Biosci201010323924519924685
- SuzukiROdaYUtoguchiNMaruyamaKProgress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubblesJ Control Release20111491364120470839
- HernotSKlibanovALMicrobubbles in ultrasound-triggered drug and gene deliveryAdv Drug Deliv Rev200860101153116618486268
- ZhouXYLiaoQPuYMUltrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularizationChin Med J (Engl)2009122222711271719951601
- HiguchiYKawakamiSHashidaMStrategies for in vivo delivery of siRNAs: recent progressBioDrugs201024319520520462284
- ManoharanMRNA interference and chemically modified siRNAsNucleic Acids Res Suppl2003311511614510407
- ChiuYLRanaTMsiRNA function in RNAi: a chemical modification analysisRNA200391034104812923253
- BraaschDAJensenSLiuYRNA interference in mammalian cells by chemically modified RNABiochemistry2003427967797512834349
- CzaudernaFFechtnerMDamesSStructural variations and stabilising modifications of synthetic siRNAs in mammalian cellsNucl Acids Res2003312705271612771196
- StewartMJPlautzGEDel BuonoLGene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in miceHum Gene Ther1992332672751643147
- FilionMCPhilipsNCMajor limitations in the use of cationic liposomes for DNA deliveryInt J Pharm19981621159170
- AberleAMTablinFZhuJWalkerNJGruenertDCNantzMHA novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicityBiochemistry19983718653365409572871
- Al-DosariMSGaoXNonviral gene delivery: principle, limitations, and recent progressAAPS J200911467168119834816
- ChellatFGrandjean-LaquerriereALe NaourRMetalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticlesBiomaterials200526996197015369684
- KimTHIhmJEChoiYJNahJWChoCSEfficient gene delivery by urocanic acid-modified chitosanJ Control Release200393338940214644588
- DieboldYJarrínMSáezVOcular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)Biomaterials20072881553156417169422
- WatariFTakashiNYokoyamaAMaterial nanosizing effect on living organisms: non-specific, biointeractive, physical size effectsJ R Soc Interface20096Suppl 3S371S38819364724
- ChoMChoWSChoiMThe impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticlesToxicol Lett2009189317718319397964
- TangJXiongLWangSDistribution, translocation and accumulation of silver nanoparticles in ratsJ Nanosci Nanotechnol2009984924493219928170
- XieGSunJZhongGShiLZhangDBiodistribution and toxicity of intravenously administered silica nanoparticles in miceArch Toxicol20108418319019936708
- UshitoraMSakuraiFYamaguchiTPrevention of hepatic ischemia–reperfusion injury by pre-administration of catalase-expressing adenovirus vectorsJ Control Release2010142343143719951728
- SakuraiHKawabataKSakuraiFNakagawaSMizuguchiHInnate immune response induced by gene delivery vectorsInt J Pharm20083541–291517640834
- ChellatFGrandjean-LaquerriereALe NaourRMetalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticlesBiomaterials200526996197015369684
- LamCWJamesJTMcCluskeyRHunterRLPulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillationToxicol Sci200477112613414514958
- DittoAJShahPNYunYHNon-viral gene delivery using nanoparticlesExpert Opin Drug Deliv20096111149116019780712
- SongELeeSKWangJRNA interference targeting Fas protects mice from fulminant hepatitisNature Med2003934735112579197
- DeVincenzoJLambkin-WilliamsRWilkinsonTA randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusPNAS2010107198800880520421463
- HeidelJDDavisMEClinical developments in nanotechnology for cancer therapyPharm Res20112818719920549313
- DavisMEThe first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinicMol Pharm2009665966819267452
- AlekuMSchulzPKeilOAtu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progressionCancer Res200868239788979819047158
- SantelAAlekuMKeilOA novel siRNA-lipoplex technology for RNA interference in the mouse vascular endotheliumGene Ther200613161222123416625243